Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dare Bioscience

3.01
+0.03521.19%
Volume:4.37K
Turnover:13.16K
Market Cap:26.60M
PE:-6.30
High:3.05
Open:2.95
Low:2.95
Close:2.97
Loading ...

Dare Bioscience announces Phase 3 plans for sildenafil cream in FSAD

TIPRANKS
·
16 Dec 2024

DarÉ Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (Fsad)

THOMSON REUTERS
·
16 Dec 2024

Dare Bioscience announces publication in Sexual Medicine on RESPOND study

TIPRANKS
·
10 Dec 2024

The Ultimate Guide to Choosing a Tokenization Platform: What You Need to Know

CoinMarketCap
·
05 Dec 2024

BRIEF-Daré Bioscience Announces $2.5 Million Grant Funding Installment To Support Further Development Of Novel Contraceptive Technology DARE-LARC1

Reuters
·
04 Dec 2024

Dare Bioscience received payment of $2.5M under grant agreement

TIPRANKS
·
04 Dec 2024

DarÉ Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology Dare-Larc1

THOMSON REUTERS
·
04 Dec 2024

Press Release: Daré Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Dow Jones
·
04 Dec 2024

Maxim Group Remains a Hold on Daré Bioscience (DARE)

TIPRANKS
·
16 Nov 2024

BRIEF-Dare Bioscience Files Prospectus For Resale Of Up To 2.8 Million Shares Of Common Stock By Selling Stockholder - SEC Filing

Reuters
·
16 Nov 2024

Dare Bioscience Files Prospectus for Resale of up to 2.8 Mln Shares of Common Stock by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
16 Nov 2024

Dare Bioscience files to sell 2.75M shares of common stock for holders

TIPRANKS
·
16 Nov 2024

Q3 2024 Dare Bioscience Inc Earnings Call

Thomson Reuters StreetEvents
·
16 Nov 2024

Dare Bioscience Inc reports results for the quarter - Earnings Summary

Reuters
·
15 Nov 2024

Dare Bioscience Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
15 Nov 2024

Dare Bioscience Inc (DARE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...

GuruFocus.com
·
15 Nov 2024

Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue Estimates

Zacks
·
15 Nov 2024

Dare Bioscience Q3 2024 GAAP EPS $(0.55) Beats $(0.73) Estimate, Sales $41.691K Miss $4.046M Estimate

Benzinga
·
15 Nov 2024

BRIEF-Daré Bioscience Announces Grant To Support Development Of A Novel Non-Hormonal Contraceptive Candidate And Expansion Of Ovaprene Pivotal Study Clinical Trial Sites

Reuters
·
13 Nov 2024

DarÉ Bioscience Announces Grant to Support Development of a Novel Non-Hormonal Contraceptive Candidate and Expansion of Ovaprene® Pivotal Study Clinical Trial Sites

THOMSON REUTERS
·
13 Nov 2024